PT  - JOURNAL ARTICLE
AU  - Xiong, Xiao-li
AU  - Wong, Kenneth Kak-yuen
AU  - Chi, Shui-qing
AU  - Zhou, Ai-fen
AU  - Tang, Jian-qiao
AU  - Zhou, Li-Shan
AU  - Chung, Patrick Ho-yu
AU  - Chua, Gilbert T
AU  - Tung, Keith TS
AU  - Wong, Ian CK
AU  - Chui, Celine SL
AU  - Li, X
AU  - Kwan, Mike Yat-wah
AU  - Wong, Wilfred Hing-sang
AU  - Ho, Marco Hok-kung
AU  - Chan, Godfrey Chi-fung
AU  - Cao, Guoqing
AU  - Li, Kang
AU  - Ip, Patrick
AU  - Chen, Peng
AU  - Tang, Shao-tao
AU  - Tam, Paul Kwong-hang
TI  - Are COVID-19 infected children with gastrointestinal symptoms different from those without symptoms? A comparative study of the clinical characteristics and epidemiological trend of 244 pediatric cases from Wuhan
AID  - 10.1101/2020.04.29.20084244
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.29.20084244
4099  - http://medrxiv.org/content/early/2020/05/05/2020.04.29.20084244.short
4100  - http://medrxiv.org/content/early/2020/05/05/2020.04.29.20084244.full
AB  - Objective COVID-19 patients presenting with gastrointestinal (GI) symptoms occur in both adults and children. To date, however, no large sample size study focusing on gastrointestinal symptoms in pediatric cases has been published. We analyzed COVID-19 infected children in Wuhan who presented with initial GI symptoms to determine the GI characteristics and epidemiological trend of the disease.Design We retrospectively analyzed 244 children patients confirmed with COVID-19 at Wuhan Children’s Hospital from 21 Jan to 20 Mar 2020. Symptomatic cases were divided into two groups according to whether the patients presented with or without GI symptoms on admission. Demographic, epidemiological, symptoms, and laboratory data were compared. We also analyzed the respective trends of case number changes of GI cases and asymptomatic cases.Results 34 out of 193 symptomatic children had GI symptoms. They had lower median age and weight, a higher rate of fever, a longer length of stay and more hematological and biochemical abnormalities than patients without GI symptoms. There was no significant difference in chest CT findings or stool SARS-CoV-2 test positive percentages between the two groups. The number of patients admitted with GI symptoms showed an overall downward trend with time. At the time of writing, 242 patients were discharged, one died, and one critically ill patient was still in the intensive care unit.Conclusion COVID-19 infected children with GI symptoms are prone to presenting with more clinical and laboratory abnormalities than patients without GI symptoms. More attention and timely hospital admission are needed for these patients.Significance of this studyWhat is already known on this subject?COVID-19 is now a pandemic with more than 1.6 million people infected worldwideAlthough attacking the respiratory tract mostly, both adult and children infected with COVID-19 can present with GI symptomsWhat are the new findings?Infants younger than two years old and presence of fever are the two risk factors of presenting with GI symptomsA high proportion of patients without GI symptoms and asymptomatic patients will have positive RT-PCR for the virus in stoolEarlier testing through contact screening of family members means more COVID-19 infected children are diagnosed when completely asymptomaticHow might it impact on clinical practice in the foreseeable future?The presence of COVID-19 in stool in infected children will have a major implication for parents and carers of young infantsIncreasing number of asymptomatic COVID-19 patients who are detected through screening could provide a useful lesson for other countries still experiencing the rise and peak of the pandemicCompeting Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe availability of all data referred to in the manuscript can be obtained via the corresponding authors